272 related articles for article (PubMed ID: 35652564)
1. Mechanisms of proton pump inhibitor-induced hypomagnesemia.
Gommers LMM; Hoenderop JGJ; de Baaij JHF
Acta Physiol (Oxf); 2022 Aug; 235(4):e13846. PubMed ID: 35652564
[TBL] [Abstract][Full Text] [Related]
2. Low gut microbiota diversity and dietary magnesium intake are associated with the development of PPI-induced hypomagnesemia.
Gommers LMM; Ederveen THA; van der Wijst J; Overmars-Bos C; Kortman GAM; Boekhorst J; Bindels RJM; de Baaij JHF; Hoenderop JGJ
FASEB J; 2019 Oct; 33(10):11235-11246. PubMed ID: 31299175
[TBL] [Abstract][Full Text] [Related]
3. Dietary Inulin Fibers Prevent Proton-Pump Inhibitor (PPI)-Induced Hypocalcemia in Mice.
Hess MW; de Baaij JH; Gommers LM; Hoenderop JG; Bindels RJ
PLoS One; 2015; 10(9):e0138881. PubMed ID: 26397986
[TBL] [Abstract][Full Text] [Related]
4. Omeprazole enhances the colonic expression of the Mg(2+) transporter TRPM6.
Lameris AL; Hess MW; van Kruijsbergen I; Hoenderop JG; Bindels RJ
Pflugers Arch; 2013 Nov; 465(11):1613-20. PubMed ID: 23756852
[TBL] [Abstract][Full Text] [Related]
5. Effect of prolonged omeprazole administration on segmental intestinal Mg
Suksridechacin N; Kulwong P; Chamniansawat S; Thongon N
World J Gastroenterol; 2020 Mar; 26(11):1142-1155. PubMed ID: 32231419
[TBL] [Abstract][Full Text] [Related]
6. Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study.
Kieboom BC; Kiefte-de Jong JC; Eijgelsheim M; Franco OH; Kuipers EJ; Hofman A; Zietse R; Stricker BH; Hoorn EJ
Am J Kidney Dis; 2015 Nov; 66(5):775-82. PubMed ID: 26123862
[TBL] [Abstract][Full Text] [Related]
7. Persistent severe hypomagnesemia caused by proton pump inhibitor resolved after laparoscopic fundoplication.
Semb S; Helgstrand F; Hjørne F; Bytzer P
World J Gastroenterol; 2017 Oct; 23(37):6907-6910. PubMed ID: 29085234
[TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitors not associated with hypomagnesemia, regardless of dose or concomitant diuretic use.
Chowdhry M; Shah K; Kemper S; Zekan D; Carter W; McJunkin B
J Gastroenterol Hepatol; 2018 Oct; 33(10):1717-1721. PubMed ID: 29514412
[TBL] [Abstract][Full Text] [Related]
9. Is there a correlation between hypomagnesemia linked to long-term proton pump inhibitor use and the active agent?
Aydın Yoldemir Ş; Zeren Ozturk G; Akarsu M; Ozcan M
Wien Klin Wochenschr; 2022 Feb; 134(3-4):104-109. PubMed ID: 33751184
[TBL] [Abstract][Full Text] [Related]
10. A Case of Severe Proton Pump Inhibitor-Induced Hypomagnesemia Refractory to Continuous Oral and Intravenous Magnesium Replenishment.
Kheir K; Al Jassem O; El Koubayati G; Haddad F
Cureus; 2024 Feb; 16(2):e54483. PubMed ID: 38516446
[TBL] [Abstract][Full Text] [Related]
11. Proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us?
Luk CP; Parsons R; Lee YP; Hughes JD
Ann Pharmacother; 2013 Jun; 47(6):773-80. PubMed ID: 23632281
[TBL] [Abstract][Full Text] [Related]
12. An approach to the diagnosis and management of a case presenting with recurrent hypomagnesemia secondary to the chronic use of a proton pump inhibitor.
dos Santos LM; Guerra RA; Lazaretti-Castro M; Vieira JG; Portes Ede S; Dias-da-Silva MR
Magnes Res; 2015 Dec; 28(4):136-45. PubMed ID: 26878253
[TBL] [Abstract][Full Text] [Related]
13. Proton Pump Inhibitor Use, Hypomagnesemia and Risk of Cardiovascular Diseases: The Atherosclerosis Risk in Communities (ARIC) Study.
Rooney MR; Bell EJ; Alonso A; Pankow JS; Demmer RT; Rudser KD; Chen LY; Lutsey PL
J Clin Gastroenterol; 2021 Sep; 55(8):677-683. PubMed ID: 33471493
[TBL] [Abstract][Full Text] [Related]
14. Common single nucleotide polymorphisms in transient receptor potential melastatin type 6 increase the risk for proton pump inhibitor-induced hypomagnesemia: a case-control study.
Hess MW; de Baaij JH; Broekman MM; Bisseling TM; Haarhuis BJ; Tan AC; Te Morsche RH; Hoenderop JG; Bindels RJ; Drenth JP
Pharmacogenet Genomics; 2017 Mar; 27(3):83-88. PubMed ID: 27926584
[TBL] [Abstract][Full Text] [Related]
15. The association of proton pump inhibitors and hypomagnesemia in the community setting.
Markovits N; Loebstein R; Halkin H; Bialik M; Landes-Westerman J; Lomnicky J; Kurnik D
J Clin Pharmacol; 2014 Aug; 54(8):889-95. PubMed ID: 24771616
[TBL] [Abstract][Full Text] [Related]
16. The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis.
Park CH; Kim EH; Roh YH; Kim HY; Lee SK
PLoS One; 2014; 9(11):e112558. PubMed ID: 25394217
[TBL] [Abstract][Full Text] [Related]
17. A case series of proton pump inhibitor-induced hypomagnesemia.
Hoorn EJ; van der Hoek J; de Man RA; Kuipers EJ; Bolwerk C; Zietse R
Am J Kidney Dis; 2010 Jul; 56(1):112-6. PubMed ID: 20189276
[TBL] [Abstract][Full Text] [Related]
18. Proton Pump Inhibitor Prophylaxis After Gastric Bypass Does Not Cause Hypomagnesemia.
Boerlage TC; van Hees CL; Huitema AD; Lauw FN
Obes Surg; 2016 Mar; 26(3):688-90. PubMed ID: 26762281
[TBL] [Abstract][Full Text] [Related]
19. Proton Pump Inhibitors and Hypomagnesemia in Older Inpatients: An Observational Study.
Anna Vermeulen Windsant-van den Tweel AM; Derijks HJ; Gadiot NPPM; Keijsers CJPW
Sr Care Pharm; 2022 Dec; 37(12):623-630. PubMed ID: 36461136
[No Abstract] [Full Text] [Related]
20. The relationship between proton pump inhibitor use and serum magnesium concentration among hemodialysis patients: a cross-sectional study.
Misra PS; Alam A; Lipman ML; Nessim SJ
BMC Nephrol; 2015 Aug; 16():136. PubMed ID: 26268579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
